Trials / Sponsors / ArmaGen, Inc
ArmaGen, Inc
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Children With MPS I Mucopolysaccharidosis I | Phase 1 / Phase 2 | 2016-10-01 |
| Completed | Extension Study of AGT-181-102 to Evaluate Long Term Safety and Activity of AGT-181 Mucopolysaccharidosis I | Phase 1 | 2015-11-01 |
| Completed | Safety and Dose Ranging Study of Human Insulin Receptor MAb-IDUA Fusion Protein in Adults and Children With MP Mucopolysaccharidosis I | Phase 1 / Phase 2 | 2015-10-01 |
| Completed | Safety and Dose Ranging Study of Insulin Receptor MAb-IDUA Fusion Protein in Patients With MPS I Mucopolysaccharidosis I | Phase 1 | 2015-07-01 |
| Completed | Safety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter Syndrome Mucopolysaccharidosis II | Phase 1 | 2015-04-01 |